SAB Biotherapeutics Inc (SABS)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | KROPOTOVA, ALEXANDRA | CHIEF MEDICAL OFFICER | Common Stock | Disposal | 473 | |
| Jun 25, 2026 | KROPOTOVA, ALEXANDRA | CHIEF MEDICAL OFFICER | Common Stock | Disposal | 988 | |
| Mar 24, 2026 | KROPOTOVA, ALEXANDRA | CHIEF MEDICAL OFFICER | Common Stock | Disposal | 988 | |
| Feb 3, 2026 | TO, LUCY | See Remarks | Stock option (right to buy) | Acquisition | 2,400,000 | 0 |
| Feb 3, 2026 | KROPOTOVA, ALEXANDRA | CHIEF MEDICAL OFFICER | Stock option (right to buy) | Acquisition | 2,400,000 | 0 |
| Feb 3, 2026 | REICH, SAMUEL J | Director, CEO | Stock option (right to buy) | Acquisition | 4,800,000 | 0 |
| Feb 3, 2026 | SULLIVAN, EDDIE JOE | Director, PRESIDENT | Stock option (right to buy) | Acquisition | 3,000,000 | 0 |
| Feb 3, 2026 | BAUSCH, CHRISTOPH LAWRENCE | CHIEF OPERATING OFFICER | Stock option (right to buy) | Acquisition | 1,800,000 | 0 |
| Jan 5, 2026 | ZACCARDELLI, DAVID | Director | Stock Option (right to buy) | Acquisition | 240,000 | 0 |
| Jan 5, 2026 | JAIN, RITA | Director | Stock Option (right to buy) | Acquisition | 240,000 | 0 |
| Dec 16, 2025 | SKYLER, JAY S | Director | Stock Option (right to buy) | Acquisition | 150,000 | 0 |
| Dec 16, 2025 | LUCERA, ERICK | Director | Stock option (right to buy) | Acquisition | 150,000 | 0 |
| Dec 16, 2025 | GIBERSON, SCOTT | Director | Stock Option (right to buy) | Acquisition | 150,000 | 0 |
| Dec 16, 2025 | ELLIAS, HELEN K. | Director | Stock Option (right to buy) | Acquisition | 150,000 | 0 |
| Dec 16, 2025 | POLVINO, WILLIAM JAMES | Director | Stock Option (right to buy) | Acquisition | 150,000 | 0 |
| Dec 16, 2025 | LINK, DAVID | Director | Stock Option (right to buy) | Acquisition | 150,000 | 0 |
| Dec 11, 2025 | KROPOTOVA, ALEXANDRA | CHIEF MEDICAL OFFICER | Common Stock | Disposal | 988 | |
| Sep 29, 2025 | MOIN, ANDREW | Director | Series B Convertible Preferred Stock | Disposal | 17,400 | |
| Sep 29, 2025 | SESSA, CAPITAL (MASTER), L.P. | Director | Common Stock | Acquisition | 1,740,000 | 1.75 |
| Sep 29, 2025 | SESSA, CAPITAL (MASTER), L.P. | Director | Series B Convertible Preferred Stock | Disposal | 17,400 | |
| Sep 29, 2025 | MOIN, ANDREW | Director | Common Stock | Acquisition | 1,740,000 | 1.75 |